Chronic Disease Management with USA’s Biofourmis

CDC estimates that 6 in 10 American adults have 1 chronic disease whereas 4 in 10 suffer from 2 or more chronic diseases. Learn how Biofourmis is changing this.

CDC estimates that 6 in 10 American adults have 1 chronic disease whereas 4 in 10 suffer from 2 or more chronic diseases. Chronic diseases, which include conditions like heart disease, stroke, diabetes and cancer, are so common in the U.S. that they drive a significant portion of the nation's healthcare costs. 

To treat such an extensive problem Biofourmis was founded by Kuldeep Singh Rajput and co-founded by Mark Niu and Maulik Majumda. They believe in providing personalized, predictive care for better outcomes. For this, they use advanced technology to improve the delivery of healthcare outside the hospital. The Boston-based company develops software to “augment” patient care and optimizes the delivery of virtual health. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers.

The venture has 2 subsets - Biofourmis Therapeutics and Biofourmis Health. For the former, pharmaceutical companies prescribe Biofourmis’ digital therapeutics for better managing chronic conditions. It follows ‘beyond the pill’ model. The latter is an AI-based remote monitoring system that helps clinicians remotely monitor patients and thereby improve patient outcomes. It follows ‘home hospital’ model. Biofourmis 

BiovitalsHF, a platform designed for heart failure medication monitoring received an FDA breakthrough device designation last year. BiovitalsHF is supposed to streamline the titration process once patients leave hospitals by collecting and analyzing data from a wearable device.

They have raised a total of $143.6 million in funding over 8 rounds. The venture has been invested by SG Innovate, MassMutual, Openspace Ventures, SpesNet, Sequoia, SoftBank and EDBI. In addition, Biofourmis will use the funding for developing, validating and commercializing several released and unreleased digital therapeutics solutions across cardiology, respiratory, oncology and pain, with a focus on the United States and key Asian markets, including the Asia Pacific, China and Japan.

Their health partners are NOVARTIS, Mayo Clinic, AstraZeneca, SingHealth, Mundipharma and more. Their 2 acquisitions are wearable biosensor leader Biovotion and Takeda Pharmaceuticals oncology-focused digital therapeutics company Gaido Health. Since COVID remote monitoring and digital therapeutics has gained momentum. Will ventures like Biofourmis make this more the forefront of medicine in the future too?

Tags : #Biofourmis #KuldeepSinghRajput #MarkNiu #MaulikMajumda #BiofourmisTherapeutics #BiofourmisHealth #chronicdisease #remotepatientmonitoring #USA-startup #MediSpeak #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024
Empowering Patients: The Role of Advocacy in Indian HealthcareMarch 26, 2024
A New Dawn in Heart Surgery: Mitral Valve Repair for 15-Year-Old PatientMarch 26, 2024